Showing results (101-110 of 1,748) with videos related to
Sort By:
Pageof 175
Journal of Immunotherapy (Hagerstown, Md. : 1997)|July 1, 1997
A prospective randomized evaluation of the prophylactic use of low-dose dopamine in cancer patients receiving interleukin-2J N Cormier, R Hurst, J Vasselli, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|July 1, 1997
Phase II trial of interleukin-2 and interferon-alpha in patients with renal cell carcinoma: clinical results and immunologic correlates of responseR M Bukowski, T Olencki, Q Wang, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|December 3, 2009
Toll-like receptor 4 signaling promotes tumor growthChe-Hsin Lee, Chao-Liang Wu, Ai-Li ShiauJournal of Immunotherapy (Hagerstown, Md. : 1997)|December 3, 2009
Soluble recombinant CMVpp65 spanning multiple HLA alleles for reconstitution of antiviral CD4+ and CD8+ T-cell responses after allogeneic stem cell transplantationAnanta Paine, Mathias Oelke, Sabine Tischer, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|December 3, 2009
Administration of cyclophosphamide changes the immune profile of tumor-bearing micePu Liu, Jade Jaffar, Ingegerd Hellstrom, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|December 3, 2009
Immune suppression by gammadelta T-cells as a potential regulatory mechanism after cancer vaccination with IL-12 secreting dendritic cellsMichael W Traxlmayr, Daniela Wesch, Alexander M Dohnal, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|December 3, 2009
Therapeutic (high) doses of rituximab activate calcium mobilization and inhibit B-cell growth via an unusual mechanism triggered independently of both CD20 and Fcgamma receptorsTammy L Unruh, Jonathan Zuccolo, Stephen A Beers, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|October 15, 2005
Failure of vaccination with idiotypic protein or DNA, (+/-IL-2), the depletion of regulatory T cells, or the blockade of CTLA-4 to prolong dormancy in mice with BCL1 lymphomaLaurentiu M Pop, Joan E Smallshaw, Thomas F Tucker, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|October 15, 2005
Prostatic acid phosphatase as a target molecule in specific immunotherapy for patients with nonprostate adenocarcinomaYi Wang, Mamoru Harada, Hirohisa Yano, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|October 15, 2005
Generating renal cancer-reactive T cells using dendritic cells (DCs) to present autologous tumorQiong J Wang, Ken-ichi Hanada, Donna Perry-Lalley, et al.Pageof 175